Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call Transcript

Aytu BioPharma, Inc. beats earnings expectations. Reported EPS is $-0.04, expectations were $-0.25. Aytu BioPharma, Inc.

Keep Reading →